t
Barclays PLC submitted a Form 8.3 disclosure on February 09, 2026, detailing its interests and dealings in the 1p ordinary shares of LIFE SCIENCE REIT PLC, with the activity date being February 06, 2026. Following these dealings, Barclays PLC reported a total long position of 274,797 shares (0.08%) and a total short position of 630,017 shares (0.18%) in LIFE SCIENCE REIT PLC. Dealings on February 06, 2026, included purchases of 34,674 shares and sales of 3,878 shares, alongside various cash-settled derivative transactions.
| Date | 9 Feb 2026 |
| Time | 12:09:14 |
| Category | Holding(s) in company |
| ID | 2794S |
|
FORM 8.3 |
|||||||
|
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY |
|||||||
|
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR |
|||||||
|
MORE |
|||||||
|
Rule 8.3 of the Takeover Code (the "Code") |
|||||||
|
1. |
KEY INFORMATION |
||||||
|
(a) |
Full name of discloser: |
|
Barclays PLC. |
||||
|
(b) |
Owner or controller of interest and short |
|
|||||
|
|
positions disclosed, if different from 1(a): |
||||||
|
(c) |
Name of offeror/offeree in relation to whose |
LIFE SCIENCE REIT PLC |
|||||
|
|
relevant securities this form relates: |
||||||
|
(d) |
If an exempt fund manager connected with an |
|
|||||
|
|
offeror/offeree, state this and specify identity of |
||||||
|
|
offeror/offeree: |
||||||
|
(e) |
Date position held/dealing undertaken: |
06 Feb 2026 |
|||||
|
(f) |
In addition to the company in 1(c) above, is the discloser making |
YES: |
|
|
|||
|
|
disclosures in respect of any other party to the offer? |
BRITISH LAND CO PLC/THE |
|
||||
|
2. |
POSITIONS OF THE PERSON MAKING THE DISCLOSURE |
||||||
|
(a) |
Interests and short positions in the relevant securities of the offeror or offeree |
|
|||||
|
|
to which the disclosure relates following the dealing(if any) |
|
|||||
|
Class of relevant security: |
1p ordinary |
||||||
|
|
Interests |
Short Positions |
|||||
|
|
Number |
(%) |
Number |
(%) |
|||
|
(1) |
Relevant securities owned |
|
|
|
|
||
|
|
and/or controlled: |
|
|
198,311 |
0.06% |
443,897 |
0.13% |
|
(2) |
Cash-settled derivatives: |
|
|
|
|
||
|
|
|
|
|
76,486 |
0.02% |
186,120 |
0.05% |
|
(3) |
Stock-settled derivatives (including options) |
|
|
|
|
||
|
|
and agreements to purchase/sell: |
|
|
0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
|
|
|
|
|
|
TOTAL: |
|
|
274,797 |
0.08% |
630,017 |
0.18% |
|
(b) |
Rights to subscribe for new securities (including directors and other executive |
|
|||||
|
|
options) |
|
|
|
|
|
|
|
Class of relevant security in relation to |
|
|
|
|
|||
|
which subscription right exists |
|
|
|
|
|||
|
Details, including nature of the rights |
|
|
|
|
|||
|
concerned and relevant percentages: |
|
|
|
|
|||
|
3. |
DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE |
||||||
|
(a) |
Purchases and sales |
|
|
|
|
|
|
|
Class of relevant |
Purchase/sale |
Number of |
Price per unit |
||||
|
security |
|
securities |
|
||||
|
1p ordinary |
Purchase |
23,897 |
0.4280 GBP |
||||
|
1p ordinary |
Purchase |
6,865 |
0.4260 GBP |
||||
|
1p ordinary |
Purchase |
2,476 |
0.4250 GBP |
||||
|
1p ordinary |
Purchase |
934 |
0.4302 GBP |
||||
|
1p ordinary |
Purchase |
501 |
0.4290 GBP |
||||
|
1p ordinary |
Purchase |
1 |
0.4310 GBP |
||||
|
1p ordinary |
Sale |
3,878 |
0.4250 GBP |
||||
|
|
|
|
|
|
|
|
|
|
(b) |
Cash-settled derivative transactions |
|
|||||
|
Class of |
Product |
Nature of dealing |
Number of |
Price per |
|||
|
relevant |
description |
|
reference |
unit |
|||
|
security |
|
|
securities |
|
|||
|
1p ordinary |
SWAP |
Decreasing Long |
1 |
0.4300 GBP |
|||
|
1p ordinary |
SWAP |
Increasing Short |
537 |
0.4250 GBP |
|||
|
1p ordinary |
SWAP |
Increasing Short |
1,738 |
0.4301 GBP |
|||
|
1p ordinary |
CFD |
Decreasing Short |
1,939 |
0.4250 GBP |
|||
|
1p ordinary |
CFD |
Increasing Short |
239 |
0.4250 GBP |
|||
|
1p ordinary |
CFD |
Increasing Short |
6,865 |
0.4260 GBP |
|||
|
1p ordinary |
CFD |
Increasing Short |
23,463 |
0.4280 GBP |
|||
|
|
|
|
|
|
|
|
|
|
(c) |
Stock-settled derivative transactions (including options) |
|
|||||
|
(i) |
Writing, selling, purchasing or varying |
|
|||||
|
Class |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
Option |
|
of |
description |
purchasing, |
of |
price |
|
date |
money |
|
relevant |
|
selling, |
securities |
per unit |
|
|
paid/ |
|
security |
|
varying etc |
to which |
|
|
|
received |
|
|
|
|
option |
|
|
|
per unit |
|
|
|
|
relates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
Exercise |
|
|
|
|
|
|
|
Class of relevant |
Product description |
Exercising/ exercised against |
Number of |
Exercise price per |
|||
|
security |
|
|
securities |
unit |
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
(d) |
Other dealings (including subscribing for new securities) |
|
|||||
|
Class of relevant |
Nature of Dealings |
Details |
Price per unit (if |
||||
|
security |
|
|
applicable) |
||||
|
|
|
|
|
||||
|
4. |
OTHER INFORMATION |
||||||
|
(a) |
Indemnity and other dealings arrangements |
|
|||||
|
Details of any indemnity or option arrangement, or any agreement or understanding, |
|
|
|||||
|
formal or informal, relating to relevant securities which may be an inducement to deal |
|
|
|||||
|
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party |
|
||||||
|
to the offer or any person acting in concert with a party to the offer: |
|
|
|
||||
|
NONE |
|||||||
|
(b) |
Agreements, arrangements or understandings relating to options or derivatives |
|
|||||
|
Details of any agreement, arrangement or understanding, formal or informal, between |
|
|
|||||
|
the person making the disclosure and any other person relating to: |
|
|
|||||
|
(i) the voting rights of any relevant securities under any option; or |
|
|
|
||||
|
(ii) the voting rights of future acquisition or disposal of any relevant securities to which |
|
|
|||||
|
any derivative is referenced: |
|
|
|
|
|
|
|
|
NONE |
|||||||
|
(c) |
Attachments |
|
|
|
|
|
|
|
Is a Supplemental Form 8 (Open Positions) attached? |
NO |
||||||
|
Date of disclosure: |
09 Feb 2026 |
||||||
|
Contact name: |
Large Holdings Regulatory Operations |
||||||
|
Telephone number: |
020 3134 7213 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|